To clarify the effect of aspirin on mortality and viral duration in adults infected with respiratory syndrome coronavirus 2 (SARS-Cov-2).After propensity score-matched (PSM) case-control analyses 24 pairs of patients were enrolled and followed up for 2 months. Both 30-day and 60-day mortality in the aspirin group were significantly lower than that in the non-aspirin group (P = .021 and P = .030, respectively). The viral duration time between the 2 groups was not significantly different (P = .942).Among adults (with hypertension, cardiovascular diseases) infected with SARS-Cov-2, low-dose aspirin medication (100 mg/day) was associated with lower risk of mortality compared with non-aspirin users.

中文翻译：

---

低剂量阿司匹林对住院成人 COVID-19 的死亡率和病毒持续时间的影响。

旨在阐明阿司匹林对感染呼吸综合征冠状病毒 2 (SARS-Cov-2) 的成人的死亡率和病毒持续时间的影响。经过倾向评分匹配 (PSM) 病例对照分析，招募了 24 对患者并随访了 2 个月。几个月。阿司匹林组的 30 天和 60 天死亡率均显着低于非阿司匹林组（分别为 P = .021 和 P = .030）。两组之间的病毒持续时间没有显着差异 (P = .942)。在感染 SARS-Cov-2 的成年人（患有高血压、心血管疾病）中，低剂量阿司匹林药物（100 毫克/天）与与非阿司匹林使用者相比，死亡风险较低。